CN Patent
CN102746255A — 具有抗肿瘤活性的化合物、制备方法及应用
Assigned to HEFEI YIGONG MEDICINE CO Ltd · Expires 2012-10-24 · 14y expired
What this patent protects
本发明涉及药物化学领域,具体涉及一类具有抗肿瘤活性的化合物(I)、制备方法、用途,以及含有它们的药物组合物,其中R和X的定义同说明书。药理试验证明本发明的化合物具有优良的抗肿瘤活性。
USPTO Abstract
本发明涉及药物化学领域,具体涉及一类具有抗肿瘤活性的化合物(I)、制备方法、用途,以及含有它们的药物组合物,其中R和X的定义同说明书。药理试验证明本发明的化合物具有优良的抗肿瘤活性。
Drugs covered by this patent
- Klisyri (TIRBANIBULIN) · Almirall
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.